トップに戻る

コメント (14)

nik_s•23時間前
I think the layman's perception of the increase in survival (~13 months versus ~6 months) will make this look underwhelming. Nevertheless, it's important to remember that the incentives for clinical trials is to only include very late-stage patients who have exhausted all other options (faster trials, smaller sample sizes, surrogate endpoints, a shot at accelerated approval, ...). The fact that a treatment shows promise for these patients that are often in very poor health and considered "hopeless" by today's medicine is exceedingly rare, and the signal from this trial is indeed strong.

The (somewhat reasonable) hope is that patients 1. with earlier forms of pancreatic cancer (non-metastatic) 2. that can undergo surgery 3. together with a (neo)adjuvant treatment with these kras inhibitors, will end up having a much lower recurrence rate and a chance for a long, healthy life.

I think this is genuinely good news worth celebrating!

mft_•1日前
For once, this isn’t hyperbole. Metastatic pancreatic cancer hasn’t had a meaningful new treatment in literally decades - it’s been brutal chemotherapy or slightly less brutal chemotherapy.

The new generation of KRAS inhibitors, of which daraxonrasib is just the first to make it to approval, is genuinely a practice-changing breakthrough.

It won’t cure people with metastatic disease, but it will help a lot live better lives for longer.

responder41•5時間前
RAS is a (class of) proteins in the membrane of your cells that are important in telling cells when it is time to grow. These proteins cycle between an "active" state that stimulates growth and an "inactive" state that doesn't. An extremely common genetic mutation that happens as a person develops cancer causes some of these cells to start making RAS proteins that do not correctly switch back to the "inactive" state. The cells with these mutations then grow and divide very rapidly and can become a tumor. Daraxonrasib works by binding the active state RAS proteins and preventing them from signalling and triggering growth. This can help prevent the tumors from growing further and potentially even shrink them as they are attacked by the immune system or other medication.

(I'm not an expert, just a fan of knowing how things work, anyone can correct me if they know better)

dang•1日前
In case others are wondering, it looks like this is a different story than this recent one:

Pancreatic cancer halted by virus injection in three patients - https://news.ycombinator.com/item?id=50563066 - Nov 2026 (157 comments)

tptacek•1日前
People who pay a lot of attention to US news might know this as the therapy former senator and UF president Ben Sasse is taking.
brooke2k•16時間前
Does the -ib medication suffix have meaning? I know -ab medications like Benralizumab, Canakinumab, etc are monoclonal antibodies. The only -ib I can remember other than this new one is Imatinib, which is also a cancer treatment, so maybe it's to do with cancer?
mmaunder•14時間前
I’m not in biotech so I don’t understand how approvals work, but it sounds like it’s already being used and that patients develop a resistance to it and it stops working. Perhaps someone in the field can help explain the dissonance between these articles.

https://www.nytimes.com/2026/09/30/science/pancreatic-cancer...

charlieyu1•1日前
I do hope to see more progress on medicine with AI.

If we can prove GRH with AI we really should be able to cure cancer.

nozzlegear•1日前
My former boss, one of the nicest, kindest and most jovial guys I've ever known, had pancreatic cancer. He quite literally wasted away before our eyes and died within a year. He was a big, round guy in life, but lying in his casket, it was like someone had let all the air out of a balloon. There wasn't anything left of him.

Pancreatic cancer is nasty (most cancers are), but the recent breakthroughs make me hopeful that we'll one day see a world where it won't be so devastating.

fadulastripe•9時間前
We can hope that the treatment will be accessible to the most still as it's been dicovered in the US
inglor_cz•10時間前
Former PM of Czechia, Topolánek, suffers from pancreatic cancer and is very open about it in the media.

Accidentally I know him personally, we lived in the same city. A tough guy, though not an angel; anyway, politics aside, I am glad that he is still alive and that he did a huge job opening the debate on pancreatic cancer and its possible prevention or early treatment.

He is also a frequent guest in podcasts and I noticed lately that his face looks really weird, as if scalded. I believe this is a side-effect of daraxonrasib. He mentioned something about experimental treatment.

sooraj_sj•11時間前
yes this is worse kind of cancer with no much tretament , would have saved steve jobs
ourmandave•22時間前
It would be amazing to live in a time we could say, "remember when cancer was a thing?"

You know, like we do now with measles.